Health Discovery (HDVY) Quarterly Cash Flow Statement

Quarterly · GAAP · USD millions
Access HDVY Annual Cash Flow →
Looking at cash flow data from Health Discovery through Sep 30 2020 provides insight into Sep 30 2021's financial flexibility across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Sep 30 2021)
9 Months
(Jun 30 2021) (Mar 31 2021) (Dec 31 2020) (Sep 30 2020)
Operating Activities
Income-2.56
Depreciation & amortization0.00
Amortization of Other Assets0.00
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Inventories Decrease /-Increase0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation1.37
Income (Loss) from Equity Method Investments0.00
Fair Value Adjustment of Warrants0.00
Gains Losses On Restructuring Of Debt-
Services Exchanged For Options-
Common Stock Issued For Services-
Gain On Payables Restructuring-
Forgiveness On Accounts Payables-
Stock Based Compensation For Directors And Consultants-
Gain Loss On Payables Restructuring-
Debt Securities Available For Sale Realized Gain Loss-
Debt Securities Available For Sale Unrealized Gain Loss-
Increase Decrease In Warrant Liability1.19
Increase Decrease In Contract With Customer Liability-
Change In Fair Value Of Common Stock Warrants Liability-
Income taxes0.00
Available-for-sale Securities, Transfers to Trading, Gains (Losses), Excluding Other than Temporary Impairments0.00
Increase (Decrease) in Employee Related Liabilities0.00
Increase (Decrease) in Accounts Payable0.30
Increase (Decrease) in Interest Payable, Net0.01
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense0.00
Other Working Capital0.00
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-0.88
Investing Activities
Capital Expenditures0.00
Sale of Capital Items0.00
Proceeds from Sale of Available-for-sale Securities, Debt0.00
Payments to Acquire Marketable Securities0.00
Real Estate Investments0.00
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities0.00
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings0.00
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.23
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities0.23
Effect of exchange rate on cash flow0.00
Discontinued operations0.92
Free Cash Flow-0.88
Total Cash Flow-0.65
4 historic quarters locked

Sign in to unlock the full Health Discovery cash flow history.

About HDVY Quarterly Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-Q filings and normalized by CSIMarket.

Source & verification

  • Form: 10-Q
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.